Published in Ann Surg on January 01, 2006
Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc (2010) 2.59
Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg (2015) 1.45
Antireflux surgery for dysplastic Barrett. World J Surg (2015) 1.40
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol (2012) 1.02
Natural history of Barrett's esophagus. World J Gastroenterol (2012) 0.93
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg (2008) 0.83
Effect of medical and surgical treatment of Barrett's metaplasia. World J Gastroenterol (2010) 0.80
The treatment of Barrett's esophagus. J Med Life (2010) 0.80
Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study. Surg Endosc (2012) 0.78
Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence. World J Gastroenterol (2008) 0.76
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Regression of low-grade noninvasive neoplasia in barrett's epithelium: should we lower our guard? Ann Surg (2007) 0.75
Surgery versus proton pump inhibitor: fair to compare? Ann Surg (2007) 0.75
Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr (2013) 0.75
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1998) 4.68
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology (1984) 3.36
Barrett's esophagus. Gastroenterology (2002) 3.27
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg (2003) 2.36
Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol (2003) 2.34
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg (2003) 2.03
Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut (1999) 1.18
Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg (2003) 1.08
Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus. Aliment Pharmacol Ther (1998) 1.02
Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol (1998) 1.01
Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus (2003) 0.98
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci (2001) 0.95
Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up. Ann Surg (2002) 0.84
Endoscopic management of GI perforations with a new over-the-scope clip device (with videos). Gastrointest Endosc (2010) 2.38
Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol (2003) 2.34
Thyroid disorders in chronic hepatitis C. Am J Med (2004) 2.19
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol (2007) 1.78
Acute small bowel obstruction caused by endometriosis: a case report and review of the literature. World J Gastroenterol (2008) 1.72
Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol (2007) 1.70
Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc (2009) 1.69
TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol (2003) 1.58
Risk factors for Barrett's esophagus: a case-control study. Int J Cancer (2002) 1.49
The short esophagus: intraoperative assessment of esophageal length. J Thorac Cardiovasc Surg (2008) 1.48
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey. EuroIntervention (2015) 1.47
Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc (2004) 1.45
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig Liver Dis (2012) 1.45
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem (2003) 1.23
The use of small intestine submucosa in the repair of paraesophageal hernias: initial observations of a new technique. Am J Surg (2003) 1.15
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol (2007) 1.08
Difficult polypectomy-giant hypopharyngeal polyp: case report and literature review. World J Gastroenterol (2013) 1.06
Radionuclide gastroesophageal motor studies. J Nucl Med (2004) 1.06
[Patient involvement in medical decision-making]. Recenti Prog Med (2012) 1.06
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities. J Am Coll Cardiol (2015) 1.05
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron. Am J Gastroenterol (2003) 1.04
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04
Cervical and mediastinal hematoma: presentation of an asymptomatic cervical parathyroid adenoma: case report and literature review. Emerg Radiol (2003) 1.03
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol (2012) 1.03
The Blue DRAGON--a system for monitoring the kinematics and the dynamics of endoscopic tools in minimally invasive surgery for objective laparoscopic skill assessment. Stud Health Technol Inform (2002) 1.03
Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol (2006) 1.01
Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature. J Clin Microbiol (2002) 1.01
Vertebroplasty and kyphoplasty: complementary techniques for the treatment of painful osteoporotic vertebral compression fractures. A prospective non-randomised study on 154 patients. Eur Spine J (2009) 1.01
A meta-analysis of endoscopic stenting as bridge to surgery versus emergency surgery for left-sided colorectal cancer obstruction. Crit Rev Oncol Hematol (2013) 1.00
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. Liver Int (2011) 1.00
Consensus statement AIGO/SICCR: diagnosis and treatment of chronic constipation and obstructed defecation (part I: diagnosis). World J Gastroenterol (2012) 0.99
Angiogenesis and invasion in gliomas. Cancer Treat Res (2004) 0.98
Radionuclide evaluation of the lower gastrointestinal tract. J Nucl Med (2008) 0.97
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J Gastroenterol (2012) 0.96
Insulated-tip knife endoscopic mucosal resection of large colorectal polyps unsuitable for standard polypectomy. Am J Gastroenterol (2007) 0.95
Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology (2006) 0.94
The role of chromoendoscopy in the surveillance of the duodenum of patients with familial adenomatous polyposis. Dig Dis Sci (2007) 0.94
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia. Clin Rheumatol (2009) 0.94
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol (2008) 0.93
Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis (2005) 0.93
The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol Med (2008) 0.92
An extended assessment of bowel habits in a general population. World J Gastroenterol (2004) 0.91
Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol (2009) 0.90
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma. Clin Cancer Res (2004) 0.90
Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res (2003) 0.90
Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. Abdom Imaging (2010) 0.90
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid (2007) 0.89
Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med (2009) 0.89
Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. J Asthma (2012) 0.89
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome. PLoS One (2013) 0.88
Endoscopic mucosal resection of large hyperplastic polyps in 3 patients with Barrett's esophagus. World J Gastroenterol (2006) 0.88
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol (2013) 0.88
Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol (2010) 0.87
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding. World J Gastrointest Pharmacol Ther (2010) 0.87
Minimal incisions vertical endoscopic lifting and fat grafting as a systematic approach to the rejuvenation of the periocular esthetic unit. Ophthal Plast Reconstr Surg (2013) 0.87
Influence of sagittal balance on spinal lumbar loads: a numerical approach. Clin Biomech (Bristol, Avon) (2013) 0.86
Does stapled functional end-to-end anastomosis affect recurrence of Crohn's disease after ileocolonic resection? Hepatogastroenterology (2003) 0.86
Quantitative assessment of intervertebral disc glycosaminoglycan distribution by gadolinium-enhanced MRI in orthopedic patients. Magn Reson Med (2008) 0.86
Laparoscopic Heller myotomy plus Dor fundoplication in 137 achalasic patients: results on symptoms relief and successful outcome predictors. Updates Surg (2011) 0.85
Surgery or Peroral Esophageal Myotomy for Achalasia: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.85
Evaluation of latent links between irritable bowel syndrome and sleep quality. World J Gastroenterol (2011) 0.85
Participation of patients and citizens in healthcare decisions in Italy. Z Evid Fortbild Qual Gesundhwes (2011) 0.85
Esophageal granular cell tumor treated by endoscopic mucosal resection. A case report and review of the literature. Dig Dis Sci (2005) 0.85
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine. J Med Virol (2005) 0.85
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. Mod Rheumatol (2011) 0.84
Sperm protein 17 is expressed in the sperm fibrous sheath. J Transl Med (2009) 0.84
Parathyroid carcinoma: the importance of high clinical suspicion for a correct management. Int J Surg Oncol (2012) 0.83
Numerical evaluation of the correlation between the normal variation in the sagittal alignment of the lumbar spine and the spinal loads. J Orthop Res (2013) 0.83
Descending perineum syndrome: are abdominal hysterectomy and bowel habits linked? Dis Colon Rectum (2005) 0.83
Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study. Cancer Lett (2007) 0.83